A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Ongoing research is needed to fully understand their risks, especially for long-term and higher-dose users. However, many ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

A new study reveals that weight lost with GLP-1 drugs, such as semaglutide, is regained within a year after stopping ...

LynFit Nutrition is a recurring segment featured on“CT BUZZ,” where Metabolic Weight Loss & Fat Burning Expert, Lisa Lynn, ...

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

New Monthly GLP-1 Could Be as Good as Ozempic, Mounjaro for Weight Loss MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight.